Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talmadge

Showing results (11-20 of 629) with videos related to

Pageof 63
Sort By:
International Immunopharmacology|February 26, 2020
A discussion on considerations in scientific integrityJames E Talmadge
International Journal of Immunopharmacology|January 4, 2001
Of mice and memoriesJ E Talmadge
Muscle & Nerve|May 8, 2000
Myosin heavy chain isoform expression following reduced neuromuscular activity: potential regulatory mechanismsR J Talmadge
Cancer Biology & Therapy|March 26, 2011
Bioluminescence in drug development for cancer: shedding light on therapeutic efficacyJames E Talmadge
Physical Review Letters|December 1, 1986
Fischbach et al. respondFischbach, Talmadge, Aronson
Progress in Clinical and Biological Research|January 1, 1984
Thymosin: immunomodulatory and therapeutic characteristicsJ E Talmadge
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2009
Models of metastasis in drug discoveryJames E Talmadge
Current Opinion in Investigational Drugs (London, England : 2000)|October 28, 2008
Bosentan for idiopathic pulmonary fibrosisTalmadge E King
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
The rational development of biological response modifiersJ E Talmadge
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Development of immunotherapeutic strategies for the treatment of malignant neoplasmsJ E Talmadge
Pageof 63

Showing results (11-20 of 629) with videos related to

Sort By:
Pageof 63
International Immunopharmacology|February 26, 2020
A discussion on considerations in scientific integrityJames E Talmadge
International Journal of Immunopharmacology|January 4, 2001
Of mice and memoriesJ E Talmadge
Muscle & Nerve|May 8, 2000
Myosin heavy chain isoform expression following reduced neuromuscular activity: potential regulatory mechanismsR J Talmadge
Cancer Biology & Therapy|March 26, 2011
Bioluminescence in drug development for cancer: shedding light on therapeutic efficacyJames E Talmadge
Physical Review Letters|December 1, 1986
Fischbach et al. respondFischbach, Talmadge, Aronson
Progress in Clinical and Biological Research|January 1, 1984
Thymosin: immunomodulatory and therapeutic characteristicsJ E Talmadge
Methods in Molecular Biology (Clifton, N.J.)|December 17, 2009
Models of metastasis in drug discoveryJames E Talmadge
Current Opinion in Investigational Drugs (London, England : 2000)|October 28, 2008
Bosentan for idiopathic pulmonary fibrosisTalmadge E King
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
The rational development of biological response modifiersJ E Talmadge
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Development of immunotherapeutic strategies for the treatment of malignant neoplasmsJ E Talmadge
Pageof 63